Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Weekly News Recap #Phispers
1. 116496-76-5
2. N-(2-ethoxy-4-nitrophenyl)acetamide
3. Acetamide,n-(2-ethoxy-4-nitrophenyl)-
4. 2'-ethoxy-4'-nitroacetanilide
5. Cds1_004703
6. Cbmicro_030367
7. Oprea1_342150
8. Divk1c_005743
9. Schembl2204761
10. Dtxsid60387001
11. Zinc5061120
12. Mfcd00994990
13. Akos001044796
14. Ab07920
15. Ps-6223
16. Bim-0030123.p001
17. Db-049909
18. Ft-0715219
19. Sr-01000223946
20. Sr-01000223946-1
21. 4-(4-ethoxycarbonylthiazol-2-yl)piperazine-1-carboxylic Acid Tert-butyl Ester
Molecular Weight | 224.21 g/mol |
---|---|
Molecular Formula | C10H12N2O4 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 224.07970687 g/mol |
Monoisotopic Mass | 224.07970687 g/mol |
Topological Polar Surface Area | 84.2 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 264 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
61
PharmaCompass offers a list of Sotatercept API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sotatercept manufacturer or Sotatercept supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sotatercept manufacturer or Sotatercept supplier.
PharmaCompass also assists you with knowing the Sotatercept API Price utilized in the formulation of products. Sotatercept API Price is not always fixed or binding as the Sotatercept Price is obtained through a variety of data sources. The Sotatercept Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4-Acetamido-3-ethoxynitrobenzene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Acetamido-3-ethoxynitrobenzene, including repackagers and relabelers. The FDA regulates 4-Acetamido-3-ethoxynitrobenzene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Acetamido-3-ethoxynitrobenzene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 4-Acetamido-3-ethoxynitrobenzene supplier is an individual or a company that provides 4-Acetamido-3-ethoxynitrobenzene active pharmaceutical ingredient (API) or 4-Acetamido-3-ethoxynitrobenzene finished formulations upon request. The 4-Acetamido-3-ethoxynitrobenzene suppliers may include 4-Acetamido-3-ethoxynitrobenzene API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4-Acetamido-3-ethoxynitrobenzene as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4-Acetamido-3-ethoxynitrobenzene API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4-Acetamido-3-ethoxynitrobenzene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4-Acetamido-3-ethoxynitrobenzene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4-Acetamido-3-ethoxynitrobenzene NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4-Acetamido-3-ethoxynitrobenzene suppliers with NDC on PharmaCompass.
4-Acetamido-3-ethoxynitrobenzene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Acetamido-3-ethoxynitrobenzene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Acetamido-3-ethoxynitrobenzene GMP manufacturer or 4-Acetamido-3-ethoxynitrobenzene GMP API supplier for your needs.
A 4-Acetamido-3-ethoxynitrobenzene CoA (Certificate of Analysis) is a formal document that attests to 4-Acetamido-3-ethoxynitrobenzene's compliance with 4-Acetamido-3-ethoxynitrobenzene specifications and serves as a tool for batch-level quality control.
4-Acetamido-3-ethoxynitrobenzene CoA mostly includes findings from lab analyses of a specific batch. For each 4-Acetamido-3-ethoxynitrobenzene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Acetamido-3-ethoxynitrobenzene may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Acetamido-3-ethoxynitrobenzene EP), 4-Acetamido-3-ethoxynitrobenzene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Acetamido-3-ethoxynitrobenzene USP).